HYPOGAMMAGLOBULINEMIA
Clinical trials for HYPOGAMMAGLOBULINEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPOGAMMAGLOBULINEMIA trials appear
Sign up with your email to follow new studies for HYPOGAMMAGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to shield cancer patients from dangerous infections
Prevention Recruiting nowThis study is testing whether adding an antibody-boosting medication called Xembify to standard care can help prevent serious bacterial infections in adults with certain blood cancers. Participants must have low antibody levels and a history of severe or frequent infections. The …
Matched conditions: HYPOGAMMAGLOBULINEMIA
Phase: PHASE3 • Sponsor: Grifols Therapeutics LLC • Aim: Prevention
Last updated Mar 30, 2026 14:35 UTC
-
New defense against infections for cancer patients
Prevention Recruiting nowThis study is testing whether a medication called IgPro20 can help prevent infections in people with multiple myeloma who have low antibody levels. The research focuses on patients receiving bispecific antibody therapy, which can increase infection risk. Participants will be rand…
Matched conditions: HYPOGAMMAGLOBULINEMIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Mar 20, 2026 14:48 UTC